bioRxivMolecular BiologyPreprint
CRISPR-ChIP delineates a Menin-dependent oncogenic DOT1L complex in MLL-leukaemia
Omer GilaniD, Charles C. BelliD, Laure Talarmain, Daniel Neville, Kathy KnezeviciD, Daniel Ferguson, Marion BoudesiD, Yih-Chih ChaniD, Chen DavidovichiD, Enid Y.N. LamiD, Mark A. DawsoniD
Abstract
The regulation of all chromatin-templated processes involves the selective recruitment of chromatin factors to facilitate DNA repair, replication, and transcription. Chromatin immunoprecipitation (ChIP) is a critical experimental method used to provide spatiotemporal evidence for the coordination of these chromatin-based events including the dynamic regulation of chromatin modifications at cis-regulatory elements. However, obtaining a global appreciation of all the factors that influence a specific chromatin event has remained challenging. Here, as a proof of concept we demonstrate the utility of coupling unbiased functional genomics with ChIP to identify the factors associated with active transcription. Specifically, we use this method to identify the major chromatin factors associated with the catalysis of two evolutionarily conserved histone modifications; H3K4me3 present at the transcriptional start site and H3K79me2 present through the gene body of actively transcribed genes. With CRISPR-ChIP, we identify all the non-redundant COMPASS complex members required for H3K4me3 and demonstrate that RNA polymerase II is dispensable for the maintenance of H3K4me3. As H3K79me2 has a putative oncogenic function in leukaemia cells driven by MLL-translocations, using CRISPR-ChIP we reveal a functional partitioning of H3K79 methylation into two distinct regulatory units. An oncogenic DOT1L complex, where the malignant driver directs the catalytic activity of DOT1L at MLL-Fusion target genes and a separate endogenous DOT1L complex, where catalytic activity is directed by MLLT10. This functional demarcation provides an explanation for the observed synergy with Menin and DOT1L inhibitors and why Menin inhibition surprisingly controls methylation of H3K79 at a critical subset of genes that sustain MLL-fusion leukaemia. Overall, CRISPR-ChIP provides a powerful tool for the unbiased interrogation of the mechanisms underpinning chromatin regulation.
- organism: human
- assay: ChIP-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: protein structure prediction
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cryo-EM structure of the human Mixed Lineage Leukemia-1 complex bound to the nucleosome
S. h. Park, A. Ayoub, … u.-s. cho·bioRxiv·Aug 16, 2019
- DOT1L inhibition reveals a distinct class ofenhancers dependent on H3K79 methylation
Laura Godfrey, Nicholas T. Crump, … Thomas A. Milne·Nature CommunicationsPeer-reviewed·Jun 26, 2019
- Menin-MLL1 complex cooperates with NF-Y to promote HCC survival
Margarita M. Dzama, Mallory Sokolowski, … Jesse R. Raab·Cell ReportsPeer-reviewed·Nov 25, 2025
- SET1/MLL complexes control transcription independently of H3K4me3
Ho Yu Alan Au, Aleksander Szczurek, … Robert J. Klose·bioRxiv·Dec 10, 2025
- A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition
Y. M. Soto-Feliciano, F. J. Sanchez-Rivera, … C. D. Allis·bioRxiv·Oct 22, 2021
- MLL1 Methyltransferase Activity is Regulated by Distinct Nucleosome Binding Modes
A. Ayoub, S. H. Park, … Y. Dou·bioRxiv·Apr 13, 2021